These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35035684)

  • 1. CDKN2B-AS1 promotes the proliferation, clone formation, and invasion of nasopharyngeal carcinoma cells by regulating miR-98-5p/E2F2 axis.
    Li Z; Cai X; Zou W; Zhang J
    Am J Transl Res; 2021; 13(12):13406-13422. PubMed ID: 35035684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating of cell cycle progression by the lncRNA CDKN2B-AS1/miR-324-5p/ROCK1 axis in laryngeal squamous cell cancer.
    Liu F; Xiao Y; Ma L; Wang J
    Int J Biol Markers; 2020 Mar; 35(1):47-56. PubMed ID: 31960744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA CDKN2B-AS1 Promotes Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma via Sponging miR-424-5p.
    Shen X; Li Y; He F; Kong J
    Cancer Manag Res; 2020; 12():6807-6819. PubMed ID: 32801906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA CDKN2B-AS1 contributes to glioma development by regulating the miR-199a-5p/DDR1 axis.
    Lu J; Chen Y; Wen L; Zhou Q; Yan S
    J Gene Med; 2022 Jan; 24(1):e3389. PubMed ID: 34559933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA TMPO-AS1 promotes cell proliferation, migration, invasion and epithelial-to-mesenchymal transition in gallbladder carcinoma by regulating the microRNA-1179/E2F2 axis.
    Sui Z; Sui X
    Oncol Lett; 2021 Dec; 22(6):855. PubMed ID: 34777589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H19/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells.
    Zhang T; Lei F; Jiang T; Xie L; Huang P; Li P; Huang Y; Tang X; Gong J; Lin Y; Cheng A; Huang W
    Curr Mol Pharmacol; 2019; 12(4):324-333. PubMed ID: 31677258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.
    Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.
    Zheng YJ; Zhao JY; Liang TS; Wang P; Wang J; Yang DK; Liu ZS
    FASEB J; 2019 Nov; 33(11):12915-12928. PubMed ID: 31557058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA CDKN2B-AS1 relieved inflammation of ulcerative colitis via sponging miR-16 and miR-195.
    Tian Y; Cui L; Lin C; Wang Y; Liu Z; Miao X
    Int Immunopharmacol; 2020 Nov; 88():106970. PubMed ID: 33182065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of lncRNA CDKN2B-AS1 in Interventional Therapy of Liver Cancer and the Mechanism under Its Participation in Tumour Cell Growth via miR-199a-5p.
    Xu L; Wu H; Pan J; Chen Z; Du L
    J Oncol; 2022; 2022():2313416. PubMed ID: 36081669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA CDKN2B-AS1 enhances LPS-induced apoptotic and inflammatory damages in human lung epithelial cells via regulating the miR-140-5p/TGFBR2/Smad3 signal network.
    Wang B; Sun Q; Ye W; Li L; Jin P
    BMC Pulm Med; 2021 Jun; 21(1):200. PubMed ID: 34126975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA FOXP4-AS1 silencing inhibits metastasis and epithelial-mesenchymal transition in nasopharyngeal carcinoma via miR-136-5p/MAPK1.
    Yan J; Zhou Q
    Anticancer Drugs; 2023 Nov; 34(10):1104-1111. PubMed ID: 36961080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircCUL2 suppresses retinoblastoma cells by regulating miR-214-5p/E2F2 Axis.
    Zhang H; Qiu X; Song Z; Lan L; Ren X; Ye B
    Anticancer Drugs; 2022 Jan; 33(1):e218-e227. PubMed ID: 34387590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN2B-AS1 participates in high glucose-induced apoptosis and fibrosis via NOTCH2 through functioning as a miR-98-5p decoy in human podocytes and renal tubular cells.
    Xiao M; Bai S; Chen J; Li Y; Zhang S; Hu Z
    Diabetol Metab Syndr; 2021 Oct; 13(1):107. PubMed ID: 34649592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CDKN2B-AS1 regulates high glucose-induced human mesangial cell injury via regulating the miR-15b-5p/WNT2B axis.
    Chang J; Yu Y; Fang Z; He H; Wang D; Teng J; Yang L
    Diabetol Metab Syndr; 2020 Dec; 12(1):109. PubMed ID: 33298110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA TP73-AS1 regulates miR-495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A.
    Dai BQ; Jiang X; Feng LC
    Kaohsiung J Med Sci; 2021 May; 37(5):361-370. PubMed ID: 33400379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2).
    Yao H; Yang L; Tian L; Guo Y; Li Y
    Cancer Cell Int; 2020; 20():138. PubMed ID: 32368184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THAP9-AS1 promotes nasopharyngeal carcinoma progression through targeted regulation of the miR-185-5p/SOX13 axis.
    Mo J; Gong Z; Liu H; Zhou L; Zhao Y
    Physiol Int; 2024 Mar; 111(1):19-34. PubMed ID: 38270621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma.
    Li S; Tang M; Zen N; Liang J; Xing X; Huang D; Liu F; Zhang X
    Front Oncol; 2022; 12():921929. PubMed ID: 35756672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.